Product
Supplier
Encyclopedia
Inquiry
Home > News > Policy & Regulation > Dr. Reddy's Gets EIR from USFDA for Cuernavaca Plant in Mexico

Dr. Reddy's Gets EIR from USFDA for Cuernavaca Plant in Mexico

Chemical Weekly 2018-04-25

Hyderabad-based Dr. Reddy’s Laboratories said it has received establishment inspection report (EIR) from the US health regulator for its Cuernavaca facility in Mexico. The company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the United States Food and Drug Administration (USFDA) was completed with zero observations. As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.

 

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.